The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004064:Digestive System / Q000187:drug effects*; D011464:Epoprostenol / Q000494:pharmacology*; D005750:Gastric Juice / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*; D011465:Prostaglandins, Synthetic / Q000494:pharmacology*; D051381:Rats; D013276:Stomach Ulcer / Q000517:prevention & control
D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D011464:Epoprostenol